UnicoCell Biomed Co., Ltd. (TPE:6794)

UnicoCell Biomed Ratios and Metrics

Market cap in millions TWD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 21, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	5,334	3,989	4,603	1,356	1,636	1,615
Market Cap Growth	30.51%	-13.33%	239.58%	-17.13%	1.26%	-
Enterprise Value	4,800	3,456	4,156	1,168	1,474	1,345
Last Close Price	87.90	68.30	83.00	32.00	42.95	42.66
PS Ratio	154.24	125.14	187.20	94.15	200.03	405.64
PB Ratio	7.35	5.83	7.72	4.06	6.22	4.70
P/TBV Ratio	7.35	5.83	7.72	4.07	6.23	4.71
EV/Sales Ratio	138.81	108.39	169.04	81.16	180.31	337.66
Debt / Equity Ratio	0.09	0.10	0.13	0.20	0.08	0.10
Asset Turnover	0.04	0.04	0.05	0.04	0.02	0.01
Inventory Turnover	1.30	1.31	0.86	0.78	0.40	0.41
Quick Ratio	33.25	21.11	29.43	13.83	7.18	10.03
Current Ratio	34.04	21.83	29.99	14.38	7.64	10.83
Return on Equity (ROE)	-14.95%	-14.53%	-18.08%	-30.55%	-28.49%	-34.25%
Return on Assets (ROA)	-9.11%	-8.79%	-10.94%	-16.17%	-15.85%	-18.62%
Return on Capital Employed (ROCE)	-14.80%	-13.70%	-14.40%	-23.20%	-31.60%	-30.30%
Earnings Yield	-2.01%	-2.33%	-1.83%	-6.73%	-5.28%	-6.76%
FCF Yield	-1.70%	-1.68%	-1.77%	-5.76%	-5.22%	-9.21%
Buyback Yield / Dilution	-5.35%	-6.68%	-29.61%	-10.12%	-6.10%	-17.04%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.